Eritoran





What happened at the 4 Feb employees meeting? I follow Eisai as an analyst and what their investor relations have said is that Eritoran was only expected to grow into a big time drug over time, so its demise may not affect their budget plans for the next few years.

And even though the slow uptake of 23mg Aricept probably means they will miss their targets for the coming fiscal year, President Naito seems determined to put a very brave face on things and doen't seem ready to make substantial cuts n the US just yet - that would look too much like an admission of failure.
 



What happened at the 4 Feb employees meeting? I follow Eisai as an analyst and what their investor relations have said is that Eritoran was only expected to grow into a big time drug over time, so its demise may not affect their budget plans for the next few years.

And even though the slow uptake of 23mg Aricept probably means they will miss their targets for the coming fiscal year, President Naito seems determined to put a very brave face on things and doen't seem ready to make substantial cuts n the US just yet - that would look too much like an admission of failure.

Trolling on cafe pharma for information? I glad I took all of my money out of the market. Do you have some sure thing penny stock tips? UGH!
 



What happened at the 4 Feb employees meeting? I follow Eisai as an analyst and what their investor relations have said is that Eritoran was only expected to grow into a big time drug over time, so its demise may not affect their budget plans for the next few years.

And even though the slow uptake of 23mg Aricept probably means they will miss their targets for the coming fiscal year, President Naito seems determined to put a very brave face on things and doen't seem ready to make substantial cuts n the US just yet - that would look too much like an admission of failure.

---------------
What do you mean? Announcing corporate-wide layoffs because speaks for itself whatever the analysts and PR says. The analysts seem to be the last to find out that a company is in trouble because they only listen to the spin from the executive office.